Integrative Analysis of Cancer Omics Data for Prognosis Modeling
Open Access
- 8 August 2019
- Vol. 10 (8), 604
- https://doi.org/10.3390/genes10080604
Abstract
Prognosis modeling plays an important role in cancer studies. With the development of omics profiling, extensive research has been conducted to search for prognostic markers for various cancer types. However, many of the existing studies share a common limitation by only focusing on a single cancer type and suffering from a lack of sufficient information. With potential molecular similarity across cancer types, one cancer type may contain information useful for the analysis of other types. The integration of multiple cancer types may facilitate information borrowing so as to more comprehensively and more accurately describe prognosis. In this study, we conduct marginal and joint integrative analysis of multiple cancer types, effectively introducing integration in the discovery process. For accommodating high dimensionality and identifying relevant markers, we adopt the advanced penalization technique which has a solid statistical ground. Gene expression data on nine cancer types from The Cancer Genome Atlas (TCGA) are analyzed, leading to biologically sensible findings that are different from the alternatives. Overall, this study provides a novel venue for cancer prognosis modeling by integrating multiple cancer types.Keywords
Funding Information
- National Institutes of Health (CA216017, CA204120)
- National Natural Science Foundation of China (91546202, 71331006)
- Bureau of Statistics of China (2018LD02, 18CG42, NA)
This publication has 45 references indexed in Scilit:
- Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutationsNucleic Acids Research, 2018
- Integrated analysis of multidimensional omics data on cutaneous melanoma prognosisGenomics, 2016
- Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesNature Genetics, 2014
- Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaBritish Journal of Haematology, 2013
- Risk factors of non-Hodgkin's lymphomaExpert Opinion on Medical Diagnostics, 2011
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung CancerCancer Discovery, 2011
- γ-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch and Amyloid Precursor Protein in the Absence of NicastrinJournal of Neuroscience, 2010
- NNK activates ERK1/2 and CREB/ATF‐1 via β‐1‐AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cellsInternational Journal of Cancer, 2006
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.1995